Paulson Acquires Stake In Salix Amid Inventory Pileup Concerns

Famous investment firm Paulson & Co has acquired an undisclosed stake in Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) as the drug maker recovers from inventory pileup issues and the exit of its chief financial officer. Paulson & Co’s acquisition in Salix headlines its health-care holdings, as it is also the third-biggest shareholder of Shire Plc. Paulson’s stake in Salix Citing people familiar with the developments, Olivia Oran, Nadia Damouni and Jessica Toonkel of Reuters report that the hedge fund firm Paulson & Co has taken a stake in the specialty pharmaceuticals company Salix Pharmaceuticals, though the size of Paulson’s stake was not immediately clear. Paulson’s…